61872-76-2 Usage
Uses
Used in Pharmaceutical Industry:
3-Chloro-N-cyclohexylpropanamide is utilized as an intermediate in the synthesis of various pharmaceuticals, contributing to the development of new drugs and medications. Its role in drug creation is vital, as it can be a precursor to compounds with therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Chloro-N-cyclohexylpropanamide is employed as a key component in the production of pesticides and other agricultural chemicals. Its integration into these products helps enhance crop protection and contribute to more efficient farming practices.
Used as a Biologically Active Substance:
3-Chloro-N-cyclohexylpropanamide also has potential applications as a biologically active substance, making it a candidate for use in the treatment of various medical conditions. Its specific medical applications are still under investigation, but its versatility and chemical properties suggest a broad range of possibilities in healthcare.
Check Digit Verification of cas no
The CAS Registry Mumber 61872-76-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,8,7 and 2 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 61872-76:
(7*6)+(6*1)+(5*8)+(4*7)+(3*2)+(2*7)+(1*6)=142
142 % 10 = 2
So 61872-76-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H16ClNO/c10-7-6-9(12)11-8-4-2-1-3-5-8/h8H,1-7H2,(H,11,12)
61872-76-2Relevant academic research and scientific papers
AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS
-
Page/Page column 37, (2011/02/24)
An aminoalkarnide of the formula I for use as a medicament to treat inflammatory, degenerative or demyelinating diseases of the CNS in a subject in need thereof.
AMIDE DERIVATIVES
-
, (2008/06/13)
Novel 1-aryl-2-carbamoylalkylaminoethanol derivatives, processes for their manufacture, pharmaceutical compositions containing them and methods of using them in the treatment of heart diseases. The compounds possess β-adrenergic blocking activity. Represe
